FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

On February 22, 2017, the U.S. Food and Drug Administration (FDA) granted approval for the use of lenalidomide as maintenance therapy after autologous hematopoietic stem cell transplantation (auto‐HSCT) for patients with multiple myeloma. The approval was based on evidence from two randomized, blind...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2018
Fag:
Regulatory Issues: FDA
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6067941/
https://ncbi.nlm.nih.gov/pubmed/29438096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0440
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker